We are live on ! Find out more
IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Fund
S&P 500
This Quarter Est. Return
+26.96%
1 Year Est. Return
+17.25%
3 Year Est. Return
+11.14%
5 Year Est. Return
+79.35%
10 Year Est. Return
–
AUM
$271M
AUM Growth
+$110M
Cap. Flow
+$20.2M
Cap. Flow %
7.47%
Top 10 Hldgs %
43.7%
Holding
66
New
21
Increased
14
Reduced
12
Closed
4

Top Buys

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$8.07M
2
ALKS icon
Alkermes
ALKS
+$7.69M
3
AERI
Aerie Pharmaceuticals
AERI
+$5.99M
4
WVE icon
Wave Life Sciences
WVE
+$5.88M
5
TVTX icon
Travere Therapeutics
TVTX
+$4.6M

Top Sells

Rank Stock Value
1
INCY icon
Incyte
INCY
+$12.4M
2
EXEL icon
Exelixis
EXEL
+$7.89M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.2M
4
LGND icon
Ligand Pharmaceuticals
LGND
+$5.95M
5
SHPG
Shire pic
SHPG
+$3.42M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HZNP
26
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.38M 1.25%
128,000
+59,000
+86% +$1.4M
ABMD
27
DELISTED
Abiomed Inc
ABMD
$3.34M 1.23%
11,700
– –
INSM icon
28
Insmed
INSM
$26.5B
$3.2M 1.18%
+110,000
New +$2.85M
ALNY icon
29
Alnylam Pharmaceuticals
ALNY
$31.7B
$3.16M 1.17%
33,800
– –
SUPN icon
30
Supernus Pharmaceuticals
SUPN
$2.57B
$3.15M 1.16%
89,953
+69,000
+329% +$2.57M
XENT
31
DELISTED
Intersect ENT, Inc
XENT
$3.09M 1.14%
96,000
– –
AMRN
32
Amarin Corp
AMRN
$297M
$2.84M 1.05%
6,850
+2,850
+71% +$1.03M
GWPH
33
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.83M 1.05%
16,800
+7,200
+75% +$1.07M
BLUE
34
DELISTED
bluebird bio
BLUE
$2.67M 0.99%
1,312
– –
AGIO icon
35
Agios Pharmaceuticals
AGIO
$2.05B
$2.46M 0.91%
36,500
– –
BIIB icon
36
Biogen
BIIB
$32.7B
$2.25M 0.83%
9,500
-7,700
-45% -$2.42M
AKCA
37
DELISTED
Akcea Therapeutics Inc
AKCA
$2.11M 0.78%
+74,608
New +$2.17M
RDUS
38
DELISTED
Radius Health, Inc.
RDUS
$2.11M 0.78%
105,829
-158,382
-60% -$2.89M
NKTR icon
39
Nektar Therapeutics
NKTR
$2.55B
$2.02M 0.74%
4,000
– –
ARRY
40
DELISTED
Array Biopharma Inc
ARRY
$1.77M 0.65%
72,500
– –
STRO icon
41
Sutro Biopharma
STRO
$353M
$1.67M 0.62%
14,665
– –
SRPT icon
42
Sarepta Therapeutics
SRPT
$2.28B
$1.64M 0.61%
13,800
-3,200
-19% -$411K
GTHX
43
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$1.63M 0.6%
+98,482
New +$1.87M
ASND icon
44
Ascendis Pharma A/S
ASND
$16.4B
$1.62M 0.6%
+13,800
New +$1.21M
MRTX
45
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.59M 0.59%
+21,700
New +$1.48M
MYOK
46
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$1.56M 0.58%
+30,000
New +$1.38M
BHVN
47
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$1.54M 0.57%
+30,000
New +$1.3M
GBT
48
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.48M 0.55%
+28,000
New +$1.38M
XLRN
49
DELISTED
Acceleron Pharma
XLRN
$1.4M 0.52%
+30,000
New +$1.32M
MYGN icon
50
Myriad Genetics
MYGN
$304M
$1.27M 0.47%
+38,365
New +$1.17M
1
2
3

Similar funds

DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
DT
Daniels + Tansey Wilmington, Delaware $289M AUM 18.06% 1-Year Est. Return
3LCM
3D/L Capital Management Hartford, Connecticut $308M AUM 13.67% 1-Year Est. Return
TFA
Triad Financial Advisors Greensboro, North Carolina $284M AUM 14.95% 1-Year Est. Return
SFG
Steward Financial Group Colleyville, Texas $315M AUM 13.78% 1-Year Est. Return
AEPLI
AH Equity Partners LSV I Menlo Park, California $315M AUM 9.31% 1-Year Est. Return
CC
Chanos & Company New York $318M AUM 4.62% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

International Biotechnology Trust's Q1 2019 Portfolio in Review

As of Q1 2019, International Biotechnology Trust held 66 positions worth $271M, up 68% from $161M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

International Biotechnology Trust deployed $20.2M of net new capital in Q1 2019, opening 21 new positions and adding to 14 existing holdings. Its largest new stake was PTC Therapeutics: 240,493 shares worth $9.05M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Incyte, an estimated $12.4M trimmed.

  • International Biotechnology Trust's largest Q1 2019 buy was PTC Therapeutics: 240,493 shares worth $9.05M.
  • International Biotechnology Trust added most to Aerie Pharmaceuticals in Q1 2019, an estimated $5.99M increase.
  • International Biotechnology Trust's biggest Q1 2019 reduction was Incyte, cutting an estimated $12.4M.
  • International Biotechnology Trust fully exited Shire pic in Q1 2019, selling an estimated $3.42M.
  • International Biotechnology Trust's ten largest holdings make up 44% of its $271M portfolio in Q1 2019.
  • International Biotechnology Trust opened 21 new positions and closed 4 in Q1 2019.
  • International Biotechnology Trust's portfolio value rose 68% quarter-over-quarter to $271M.

Based on International Biotechnology Trust's 13F filing for Q1 2019, filed 14 May 2019.